| Ytd | 145.40% | |
| 1y | 844.69% |
| Open | 8.52 | Prev Close | 8.55 | Low | 8.54 | High | 8.55 | Mkt Cap | 801.08M |
| Vol | 0.00 | Avg Vol | 4.05M | EPS | -0.99 | P/E | -8.63 | Forward P/E | -2.93 |
| Beta | -0.17 | Short Ratio | 2.44 | Inst. Own | 45.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 6.67 | 200-d Avg | 2.75 | 1yr Est | 8.40 |
- Addition of dordaviprone strengthens Jazz's late-stage oncology pipeline and reinforces commitment
Investing in biotech can be highly rewarding but is fraught with risks; understanding past catalysts
New Drug Application (NDA) for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
DURHAM, N.C., March 07, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on Mar
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is inves
Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals are included in this Anal
CMRX and JAZZ are in the spotlight this week following an acquisition agreement.
JAZZ's acquisition of CMRX is set to add a rare high-grade brain tumor drug currently under the FDA'
NEW YORK , March 5, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"),
NEW YORK , March 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investiga
On Tuesday, Jazz Pharmaceuticals plc JAZZ agreed to acquire Chimerix Inc CMRX for $8.55 per share in
Jazz Pharmaceuticals will acquire biotech firm Chimerix for about $935 million to gain access to its
-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tu
-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tu
The company holds potential to have first approval of dordaviprone for the treatment of recurrent H3
Chimerix (CMRX) made it through our "Recent Price Strength" screen and could be a great choice for i
DURHAM, N.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on Febr
Chimerix stock surges 324% in three months following NDA submission for high-grade glioma drug, dord
DURHAM, N.C., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
During Monday's trading, 1214 companies set new 52-week lows.
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e
During Wednesday's morning trading, 254 companies set new 52-week highs.
Stocks That Hit 52-Week Lows On Thursday
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
Stocks Which Set New 52-Week Low Friday, October 26th
Stocks Which Set New 52-Week Low Yesterday, October 23rd